OncView™ Podcast: Immunotherapy Response Monitoring in Lung Cancer
In an OncView program, Roy Herbst, MD, PhD, touched on clinical decision-making, monitoring response, and the potential treatment options available for treating non–small cell lung cancer.
As part of its OncView™ video series, CancerNetwork® spoke with Roy Herbst, MD, PhD, chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, about currently available treatment options and strategies for selecting immunotherapy in the treatment of non–small cell lung cancer (NSCLC).
In the video series, Herbst discussed the following:
- Treatment Options in Non–Small Cell Lung Cancer
- Monitoring Response to Therapy in NSCLC
- Role of ctDNA in Monitoring Treatment Response in NSCLC
- Clinical Decision-Making in NSCLC
- Recap: Monitoring With ctDNA for Immunotherapy Response in Lung Cancer
To watch more videos in the CancerNetwork® OncView™ series, visit cancernetwork.com/oncview.
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
